Alpha Teknova (TKNO)

• Market cap: $397M
• 1 day: -6.76%
• 5 days: -8.02%
• 1 month: -8.59%
• 3 months: 2.34%
• 6 months: 44.10%
• Year to date: -10.46%
• 1 year: 148.33%
• 5 years: -70.20%
• 10 years: -70.20%
• Sector: Healthcare
• Industry: In Vitro & In Vivo Diagnostic Substances

About: Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Employees: 211

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 7

114% more capital invested

Capital invested by funds: $24.9M [Q3] → $53.2M (+$28.3M) [Q4]

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

44% more funds holding

Funds holding: 32 [Q3] → 46 (+14) [Q4]

2.31% more ownership

Funds ownership: 9.64% [Q3] → 11.95% (+2.31%) [Q4]